Red Light Therapy Contraindications: When Not to Use It

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

Whole-body photobiomodulation (PBM) showed no benefits for exercise recovery or performance in a 2025 systematic review of five studies with 105 participants.
PBM's efficacy for age-related macular degeneration (AMD) remains debated, according to a 2024 systematic review.
PBM has a low incidence of adverse events, reinforcing its safety profile.
Localized PBM has shown significant pain reduction in some chronic pain conditions like fibromyalgia and neuropathy, with fourteen studies included in a 2026 systematic review covering this area.

Photobiomodulation (PBM), often known as red light therapy, is a non-invasive therapeutic procedure that has garnered significant attention for various health applications. However, its effectiveness is not universal, and understanding when it may not be beneficial is crucial for practitioners and individuals alike. Our analysis of recent research highlights specific areas where PBM's efficacy is still under debate or has shown no significant benefit. For instance, a 2025 systematic review, which screened 193 studies and included five, concluded that whole-body PBM does not improve exercise performance or recovery Systematic review on whole-body PBM for exercise. Similarly, its role in managing age-related macular degeneration (AMD) remains controversial, as detailed in a 2024 systematic review that examined randomized controlled trials. While PBM generally boasts a low incidence of adverse events, making it a safe option for many, it is important to align expectations with evidence-based outcomes. This guide explores the specific scenarios where PBM might not be the most effective choice and where its benefits are still being rigorously evaluated.

What is Photobiomodulation (PBM)?

Photobiomodulation, or PBM, is a therapeutic approach that uses light to stimulate cellular function. It is a non-invasive treatment method that involves irradiating local areas of the skin. This irradiation is performed with specific types of light, typically red and near-infrared lasers or light-emitting diodes (LEDs). The core principle behind PBM is its ability to modulate mitochondrial activity within cells. Mitochondria are often called the "powerhouses" of the cell because they produce adenosine triphosphate (ATP), the main energy currency of the cell. By influencing this activity, PBM aims to bring about various therapeutic effects at a cellular level, which then translate into broader physiological benefits.

The Mechanism of Action

The exact mechanisms by which PBM exerts its effects are complex and still under investigation, but the fundamental idea revolves around light absorption by chromophores within the cells. These chromophores, primarily cytochrome c oxidase in the mitochondria, absorb photons from the red and near-infrared light. This absorption leads to a cascade of intracellular reactions. One key outcome is the modulation of mitochondrial activity. This modulation can enhance ATP production, reduce oxidative stress, and influence signaling pathways that promote cellular repair and regeneration. The non-invasive nature of PBM means it does not require incisions or injections, offering a gentler alternative for various conditions.

Types of Light Used in PBM

PBM typically uses light in the red and near-infrared spectrum. Red light generally falls within wavelengths of 600-700 nanometers (nm), while near-infrared (NIR) light ranges from 700-1100 nm. These specific wavelengths are chosen because they can penetrate tissues effectively without causing thermal damage, unlike higher-energy lasers used in surgical procedures. Lasers and LEDs are the primary devices employed for delivering this light. Lasers emit coherent, monochromatic light, meaning the light waves are in phase and of a single color. LEDs, on the other hand, produce non-coherent light, which spreads out more. Both have been shown to be effective in various PBM applications, with the choice often depending on the specific therapeutic goal and the depth of penetration required. The technology aims to deliver light energy to the cells, triggering beneficial biological responses without causing harm.

General Applications and Goals

The overarching goal of PBM is to halt or reverse the progression of various conditions and to promote healing and pain relief. For instance, in conditions like age-related macular degeneration (AMD), PBM is explored for its potential to modulate mitochondrial activity in retinal cells, aiming to slow or reverse vision loss. In chronic pain management, PBM seeks to reduce inflammation and promote tissue repair, thereby alleviating discomfort. However, as with any therapeutic approach, the efficacy of PBM can vary significantly depending on the specific condition, the treatment protocol, and individual patient factors. It's crucial to distinguish between promising areas of research and those where evidence is still emerging or inconclusive. Our understanding of PBM continues to evolve with ongoing research, refining its applications and identifying its true potential and limitations.

Does Whole-Body Red Light Therapy Help with Exercise Performance or Recovery?

A 2025 systematic review concluded that whole-body photobiomodulation (PBM) shows no evidence of benefits for exercise recovery or performance. This comprehensive review analyzed findings from five studies, which collectively included 105 physically active participants. While localized PBM has been studied and shown some promise for improving exercise performance and recovery in specific areas, the broader application of whole-body PBM does not appear to yield similar results based on the current evidence. The review aimed to compare the effects of whole-body PBM to the established benefits often seen with localized PBM applications.

Findings on Exercise Performance and Recovery

The systematic review, published in Lasers in Medical Science in 2025, specifically searched PubMed, The Cochrane Library, EBSCO, and Google Scholar for relevant studies. Researchers included studies involving human participants who received whole-body PBM in the red or near-infrared spectrum either before or after exercise. The primary outcomes of interest were enhancements in performance or recovery. Despite the thorough search, only five studies met the inclusion criteria out of 193 initially screened. These five studies, involving a total of 105 physically active participants of both sexes and engaging in different exercise modalities, consistently reported no benefit of whole-body PBM on biomarkers of fatigue or overall exercise performance. This suggests that the generalized application of red light across the entire body may not deliver the targeted physiological responses needed to enhance athletic capabilities or accelerate post-exercise recuperation.

Impact on Sleep Quality

Interestingly, while whole-body PBM did not demonstrate benefits for exercise performance or recovery, two of the five studies identified in the 2025 review reported a positive impact on sleep quality. Participants using whole-body PBM experienced better sleep, which was determined through subjective questionnaires and data from commercial sleep trackers. These improvements were also supported by objective measurements, including higher serum melatonin levels and a lower nocturnal heart rate. Melatonin is a hormone crucial for regulating sleep-wake cycles, and a lower nocturnal heart rate often indicates deeper, more restorative sleep. This finding suggests that whole-body PBM might have an application in improving general well-being through sleep enhancement, even if it doesn't directly boost athletic metrics. However, this benefit on sleep quality does not translate into improved physical performance or recovery from exercise, according to the same review.

Discrepancies with Localized PBM

The conclusions drawn from the 2025 systematic review highlight a notable discrepancy between whole-body and localized PBM applications. Localized PBM, which involves irradiating a specific muscle group or injury site, has shown more promising results in various studies for improving exercise performance and speeding up recovery. This difference could be attributed to several factors. Localized treatment allows for a higher concentration of light energy to be delivered to the specific tissues that require it most, potentially eliciting a more potent cellular response. In contrast, whole-body PBM might diffuse the energy too broadly, or the dosage might not be optimized for specific tissue targets across the entire body. Further research is necessary to fully understand these discrepancies and to identify whether specific parameters or application methods could make whole-body PBM more effective for athletic purposes. For now, based on the evidence from the 2025 review, those seeking to improve exercise performance or recovery should look to localized PBM applications rather than whole-body treatments.

Is Red Light Therapy Effective for Age-Related Macular Degeneration (AMD)?

The efficacy and clinical relevance of photobiomodulation (PBM) as a potential approach for managing dry age-related macular degeneration (AMD) remain debated. A 2024 systematic review and meta-analysis of randomized clinical trials sought to clarify this issue. Age-related macular degeneration is a leading cause of vision loss, particularly in older adults, and treatments for its dry form are limited. PBM offers a controversial approach, with the hypothesis that it could halt or reverse progression by modulating mitochondrial activity in the retinal cells. However, the comprehensive review underscores that definitive conclusions regarding its effectiveness are still elusive.

The Debate Around PBM for AMD

"Age-related macular degeneration (AMD) is a leading cause of vision loss. Photobiomodulation (PBM) offers a controversial approach for managing dry AMD, aiming to halt or reverse progression through mitochondrial activity modulation," stated Tiago N O Rassi et al. in Int J Retina Vitreous. 2024 PBM efficacy in age-related macular degeneration. This statement encapsulates the core of the ongoing discussion. While the theoretical basis for PBM in AMD—enhancing mitochondrial function in compromised retinal cells—is compelling, translating this into consistent, clinically significant outcomes has proven challenging. The controversy stems from a lack of robust, consistently positive evidence across all studies, as well as variations in study designs and patient populations. Patients seeking treatment for AMD must understand that PBM is not yet a universally accepted or proven therapy for this condition.

Findings from the 2024 Systematic Review

The 2024 systematic review, published in International Journal of Retina and Vitreous, performed a systematic search across major medical databases including PubMed, Embase, and Cochrane databases. The researchers aimed to identify randomized controlled trials (RCTs) that compared PBM against a sham treatment in patients diagnosed with dry AMD. They conducted trial sequential analysis (TSA) and minimal clinically important difference (MCID) calculations to evaluate both statistical and clinical significance, applying a random-effects model with 95% confidence intervals (CI). Despite this rigorous methodology, the review concluded that the efficacy and clinical relevance of PBM for managing dry AMD are still under debate. This means that while some individual studies might show promising results, the overall body of evidence, when rigorously analyzed across multiple trials, does not yet provide a clear and consistent picture of benefit sufficient for widespread clinical recommendation. This highlights the need for further, well-designed research to resolve the existing uncertainties. The fact that its efficacy remains controversial suggests that patients should approach PBM for AMD with caution and tempered expectations, always in consultation with their ophthalmologist.

Why the Controversy Persists

The persistence of controversy surrounding PBM for AMD can be attributed to several factors. One major issue is the heterogeneity of study protocols. Different trials use varying wavelengths of light, different power densities, treatment durations, and frequencies. These variations make it difficult to compare results across studies and to identify an optimal treatment protocol. Furthermore, patient populations can differ in terms of disease severity, duration, and genetic predispositions, which may influence treatment responses. The subjective nature of some vision assessments and the challenges in blinding participants to light exposure in sham-controlled trials also contribute to the complexity. For a therapy to move from "controversial" to "established," there needs to be a consistent demonstration of significant clinical benefit that is reproducible across diverse settings and patient groups. Until such evidence emerges, PBM for AMD remains an experimental approach, and individuals should be aware that its benefits are not yet definitively proven.

When is Red Light Therapy Beneficial for Chronic Pain?

Photobiomodulation (PBM) stands out as a promising therapeutic alternative for the management of chronic pain. A 2026 systematic review, which included fourteen studies, found that most trials demonstrated significant pain reduction with PBM. This was particularly evident in specific conditions such as fibromyalgia and neuropathy. The review also reported that some studies observed functional gains and improved quality of life for patients. These findings reinforce PBM's potential as a valuable tool in the complex landscape of chronic pain management, offering a non-pharmacological option for relief.

Evidence for Pain Reduction

"Photobiomodulation (PBM) stands out as a promising therapeutic alternative for the management of chronic pain, but there is still controversy regarding its efficacy and safety, given the diversity of protocols and populations evaluated," noted Luciano Maia Alves Ferreira et al. in Front Integr Neurosci. 2026 Photobiomodulation in chronic pain trials. Despite this ongoing discussion, the overall trend in the 2026 systematic review indicates a strong potential for PBM to reduce pain intensity. The review systematically searched PubMed, Embase, Scopus, LILACS, and MEDLINE, including articles published between September 2015 and September 2025. It focused on randomized clinical trials that compared PBM protocols to placebo, sham, or conventional care. The primary outcome investigated was pain intensity, and the results clearly showed significant reductions in pain across a majority of the included trials. This suggests that when applied correctly, PBM can provide tangible relief for individuals suffering from persistent pain.

Impact on Function and Quality of Life

Beyond just pain reduction, the 2026 systematic review also looked at secondary outcomes, including functional effects and the impact on quality of life. In some of the fourteen studies reviewed, PBM treatment led to observable functional gains. This means patients were able to perform daily activities with greater ease or experience improvements in their physical capabilities that were previously hindered by chronic pain. Furthermore, improved quality of life was another positive outcome reported in some trials. Chronic pain can severely diminish a person's overall well-being, affecting their mental health, social interactions, and ability to enjoy life. The ability of PBM to positively influence these aspects makes it a particularly attractive option for a holistic approach to chronic pain management. These benefits extend beyond mere symptom suppression, aiming to restore a greater sense of normalcy and comfort to patients' lives.

Specific Chronic Pain Conditions Benefiting from PBM

The 2026 systematic review covered populations with various chronic pain conditions. These included fibromyalgia, peripheral neuropathies, orofacial pain, and musculoskeletal pain. The most significant pain reductions with PBM were observed particularly in cases of fibromyalgia and neuropathy. Fibromyalgia is a chronic disorder characterized by widespread pain, fatigue, and other symptoms. Neuropathic pain, resulting from nerve damage, can be notoriously difficult to treat. The consistent positive findings in these specific conditions highlight PBM as a targeted intervention where conventional treatments might fall short or carry significant side effects. The low incidence of adverse events associated with PBM, as noted in the same review, further strengthens its appeal for long-term management of these conditions. For individuals struggling with these specific types of chronic pain, PBM offers a promising, evidence-backed avenue for relief, improving not just pain levels but also their ability to function and enjoy life.

What is the Safety Profile of Red Light Therapy?

The safety profile of photobiomodulation (PBM) is generally considered to be excellent, with a low incidence of adverse events reported across various studies. This low occurrence of side effects reinforces PBM's reputation as a safe therapeutic method. However, it is important to acknowledge that the diversity of technical parameters used in different studies—such as varying wavelengths, power outputs, and treatment durations—can compromise the standardization of results. Despite these inconsistencies, the overall consensus points to PBM as a well-tolerated treatment option.

Low Incidence of Adverse Events

Multiple systematic reviews and clinical trials consistently report a remarkably low incidence of adverse events associated with PBM. For example, the 2026 systematic review on PBM in chronic pain, which included fourteen studies, specifically investigated the occurrence of adverse events as a secondary outcome. The review concluded that the incidence of these events was low, strongly reinforcing the method's safety. This means that serious side effects are rare, and any minor effects are typically transient and mild. This favorable safety profile is a significant advantage of PBM compared to many pharmacological treatments for chronic conditions, which often come with a longer list of potential side effects, some of which can be severe. The non-invasive nature of PBM, which uses light rather than drugs or surgery, contributes significantly to its safety. Patients undergoing PBM treatments can generally expect a comfortable experience with minimal risk.

Factors Contributing to Safety

The inherent properties of red and near-infrared light contribute to PBM's safety. These wavelengths are non-ionizing, meaning they do not have enough energy to remove electrons from atoms or molecules, which is the type of radiation that can cause DNA damage and increase cancer risk. Instead, PBM light interacts with cellular components in a way that stimulates biological processes without causing destructive thermal effects, provided the power density and exposure times are within therapeutic ranges. The careful calibration of PBM devices by manufacturers and the adherence to established protocols by practitioners further ensure that treatments are delivered safely. The absence of systemic drug absorption also eliminates concerns about drug interactions or allergic reactions that can be common with pharmaceutical interventions. This makes PBM a suitable option for a wide range of patients, including those who may be sensitive to medications or unable to undergo more invasive procedures.

Challenges in Standardization

Despite its strong safety record, the diversity of technical parameters used in PBM research and clinical practice presents a challenge for standardization. Different studies and clinics may employ devices with varying wavelengths (e.g., 630 nm, 810 nm, 980 nm), power outputs (milliwatts to watts), energy densities (joules per square centimeter), pulsing frequencies, and treatment durations. This heterogeneity can lead to variability in treatment outcomes, making it difficult to establish universally optimal protocols for specific conditions. While the method remains safe, determining the most effective and consistently reproducible treatment parameters requires more standardized research. The 2026 systematic review on chronic pain explicitly mentioned that "the heterogeneity of technical parameters compromises the standardization of results." This means that while safety is rarely a concern, achieving consistent therapeutic efficacy across different settings and devices is an ongoing area of research and development. This continuous refinement aims to maximize the benefits of PBM while maintaining its excellent safety profile.

Are There Specific Conditions Where PBM Shows Promise?

Photobiomodulation (PBM) has indeed shown promise in several specific chronic pain conditions, distinguishing itself as a viable therapeutic option where other treatments may fall short. Our review highlights its effectiveness particularly in areas involving musculoskeletal and neuropathic pain. This targeted efficacy helps us understand when to recommend PBM and when its benefits are more speculative.

Fibromyalgia and Neuropathic Pain

PBM has demonstrated significant potential in alleviating the symptoms of fibromyalgia. This chronic disorder is characterized by widespread musculoskeletal pain, fatigue, and localized tenderness. The 2026 systematic review on chronic pain specifically noted that most trials showed significant pain reduction with PBM, particularly in fibromyalgia. This aligns with earlier research, such as a 2002 study published in Lasers in Medical Science, which investigated the "Efficacy of low power laser therapy in fibromyalgia: a single-blind, placebo-controlled trial" Efficacy of low power laser therapy in fibromyalgia. Such studies provide a foundation for understanding PBM's role in managing this complex condition.

Similarly, PBM has shown considerable promise for peripheral neuropathies. These conditions involve damage to nerves outside the brain and spinal cord, leading to pain, numbness, and weakness. The systematic review from 2026 underscored that PBM was effective in reducing pain in neuropathy patients. This suggests that the light therapy can help in nerve regeneration and reduce inflammation, leading to symptomatic relief. The mechanism likely involves the light's ability to stimulate cellular repair processes and improve mitochondrial function in damaged nerve cells, which are crucial for nerve health.

Orofacial and Musculoskeletal Pain

Beyond fibromyalgia and neuropathy, PBM has also shown benefits for orofacial pain. This category includes pain conditions affecting the mouth, face, and jaws, which can be debilitating and impact daily functions like eating and speaking. The 2026 systematic review covered populations with orofacial pain, indicating positive outcomes. The localized application of red and near-infrared light can target specific pain points in the facial region, reducing inflammation and muscle tension.

Furthermore, PBM has demonstrated efficacy in various forms of musculoskeletal pain. This broad category encompasses pain in muscles, bones, ligaments, tendons, and nerves. Whether it's chronic back pain, knee pain, or shoulder discomfort, PBM can be a valuable adjunct therapy. The systematic review included studies on musculoskeletal pain, where functional gains and improved quality of life were observed in some participants. This suggests PBM's ability to accelerate tissue repair, reduce inflammation, and alleviate pain in a localized manner, making it a versatile tool for many common chronic pain conditions. The low incidence of adverse events associated with PBM makes it an attractive alternative or complementary therapy for these widespread conditions.

Frequently Asked Questions

Is red light therapy safe for everyone?

Red light therapy, or photobiomodulation (PBM), generally has a low incidence of adverse events, reinforcing its safety profile. However, its suitability for everyone can depend on specific health conditions and the diversity of technical parameters used in treatments. While considered safe for most, individuals with certain conditions like active cancer or those on photosensitizing medications should consult a healthcare provider before starting PBM. The 2026 systematic review on chronic pain confirmed the low incidence of adverse events, strengthening its reputation as a safe therapeutic option.

Can red light therapy improve athletic performance?

Based on recent research, whole-body red light therapy has not shown evidence of improving athletic performance or recovery. A 2025 systematic review, which included five studies with 105 physically active participants, concluded that whole-body PBM provided no benefits for exercise recovery or performance Systematic review on whole-body PBM for exercise. While localized PBM has been studied for these purposes, the generalized, whole-body application does not appear to yield the desired athletic enhancements.

Does red light therapy help with eye conditions like AMD?

The efficacy of red light therapy for age-related macular degeneration (AMD) remains a subject of debate. A 2024 systematic review investigating PBM for dry AMD found that its efficacy and clinical relevance are still controversial PBM efficacy in age-related macular degeneration. While PBM aims to modulate mitochondrial activity to potentially halt or reverse AMD progression, definitive evidence supporting its widespread clinical use is still lacking.

What types of pain can red light therapy treat?

Red light therapy shows promise in treating several types of chronic pain, particularly fibromyalgia and neuropathies. A 2026 systematic review of fourteen studies indicated significant pain reduction with PBM in these conditions. It also showed benefits for orofacial pain and various musculoskeletal pain conditions, with some studies observing functional gains and improved quality of life. The review included articles published between September 2015 and September 2025, highlighting its broad potential.

Are there any known side effects of red light therapy?

The known side effects of red light therapy are generally minimal and rare. Research consistently reports a low incidence of adverse events, reinforcing the method's safety. For instance, the 2026 systematic review on PBM for chronic pain noted the low occurrence of adverse events. Minor, temporary effects might include mild redness or warmth in the treated area, but serious side effects are highly uncommon due to the non-invasive nature and specific wavelengths of light used.